In situ opthalmic gels: A developing trend

International Journal of Pharmaceutical Sciences Review and Research

Volumn 7, Issue 1, 2011, Pages 8-14

  Rajas, Nittur Jayaprakash ^a   Kavitha, Kunchu ^a   Gounder, Theetha ^a   Mani, Tamizh ^a  

^a BHARATHI COLLEGE OF PHARMACY   (India)

Author keywords

In situ gels; Ion exchange triggered; ph dependent; Temperature dependent

Indexed keywords

ALGINIC ACID; BLOCARDEN; CARBOMER; CIPROFLOXACIN; GATIFLOXACIN; GELRITE; HYDROXYPROPYLMETHYLCELLULOSE; INDOMETACIN; METHYLCELLULOSE; POLOXAMER; POLYSACCHARIDE; TIMOLOL MALEATE; UNCLASSIFIED DRUG; XYLOGLUCAN;

CONTROLLED DRUG RELEASE; CORNEA; DRUG ADMINISTRATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GELATION; HYDROGEL; IN SITU GEL; ION EXCHANGE; OPHTHALMOLOGY; PH; POLYMERIZATION; REVIEW; TEMPERATURE DEPENDENCE;

EID: 80052664238     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Rathore KS, Nema RK, Ishibashi Tejraj, Yokoi N, Born JA, Tiffany MJ, Komuro A. Review on Ocular inserts International Journal of Pharm Tech Research 1(2); 2009: 164-169.
2. Rathore KS, Nema RK. Formulation and evaluation of ophthalmic films for timolol maleate. Planta indica4; 2008:49-50.
3. Keister JC, Cooper ER, Missel PJ, Lang JC, Hager DF. Limits on optimizing ocular drug delivery Journal of Pharmaceutical Sciences 80; 1991: 50-53.
4. J.L. Greaves, C.G. Wilson, A.T. Birmingham. Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects. British journal of clinical pharmacology 35; 1993: 188-192.
5. Mazor Z, Ticho U, Rehany U, Rose L, Piloplex. A new longacting pilocarpine polymer salt. B: comparative study of the visual effects of pilocarpine and Piloplex eye drops British journal of ophthalmology 63; 1979: 58-61.
6. Gangrade N.K, Gaddipati N.B, Ganesan M.G, Reddy I.K, Ocular Therapeutics and Drug Delivery, Technomic Publishing, Lanchester.1996; 377-403.
7. Olejnik O, Mitra A.K, Novel Control Drug Delivery Systems, Marcel Dekker, New York.1993; 117-197.
8. Sanzgiri Y.D, Maschi S, Crescenzi V, Callegaro L, Topp E.M, Stella V.J. Gellan-based systems for ophthalmic sustained delivery of methyl prednisolone. Journal of Controlled Release 26; 1993:195-201.
9. Durrani A.M, Davies N.M, Thomas M, Kellaway I.W. Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system. International journal of pharmaceutics 88; 1992: 409-415.
10. Fitzgerald P, Hadgraft J., Kreuter J, Wilson C.G. A gamma scintigraphic evaluation of microparticulate ophthalmic delivery systems. Liposomes and nanoparticles. International journal of pharmaceutics 40; 1987: 81-84.
11. Divyesh H. Shastri, Lakshmanbhai D. Patel. A Novel Alternative to Ocular Drug Delivery System: Hydrogel International journal of pharmaceutical research 2(1); 2010:1-13.
12. Bourlais C.L, Acar L, Zia H, Sado P.A, Needham T, Leverge R. Ophthalmic Drug Delivery Systems-Recent advances progress in retinal and eye research 17;1998:33-58.
13. Robinson JR. Ocular evaluation of polyvinyl alcohol vehicle in rabbits. Journal of pharmaceutical sciences 64; 1975:1312-1316.
14. Felt O, Baeyens V, Zignani M, Buri P, Gurny R. Mucosal drug delivery ocular Encyclopaedia of controlled drug delivery, volume 2, University of Geneva, Geneva, Switzerland 1999: 605-622.
15. Soppinath KS, Aminabhavi, TM, Dave AM, Kumar SG, Rudzinski WE. Stimulus responsive"smart" hydrogels as novel drug delivery systems. Drug Development and Industrial Pharmacy 28; 2002: 957-74.
16. Van M. In Biopharmaceutics of ocular drug delivery, Ed. P. Edman, CRC press, Boca Raton, Fla 1993:27-42.
17. Wichterle O, Lim D. Hydrophilic gels for biological use Nature 185; 1960:117-118.
18. Miller S.C, Donovan M.D. Effect of Poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. International journal of pharmaceutics 12; 1982:147-152.
19. Gurny R, Boye T, Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. Journal of Controlled Release 2; 1985: 353-361.
20. Moorhouse R, Colegrove G.T, Sandford P.A, Baird J.K, Kang K.S. A new gel forming polysaccharide, Solution Properties of Polysaccharides. ACS Symposium series, Washington-DC. 1981; 111-124.
21. Hoffman A.S, Afrassiabi A, Dong A. Thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions. Journal of Controlled Release 4; 1986: 213-222.
22. Gariepy E.R, Leroux J.C. In situ-forming hydrogels review of temperature-sensitive systems. European journal of pharmaceutics and bio pharmaceutics 58; 2004: 409-426.
23. Cabana A, Ait-Kadi A, Juhasz J. Study of the gelation process of polyethylene oxide-polypropylene oxide- polyethylene oxide copolymer (Poloxamer 407) aqueous solutions. Journal of colloid and interface sciences 190; 1997: 307-312.
24. Harrington W.F, Von Hippel W.F. The structure of collagen and gelatin. Advances in Protein Chemistry 1; 1961: 1-138.
25. Shirakawa M, Yamatoya K, Nishinari K. Tailoring xyloglucan properties using an enzyme. Food Hydrocolloids 22; 1998: 25-28.
26. Miyazaki S, Suisha F, Kawasaki N., Shirakawa M, Yamatoya K, Attwood D. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. Journal of Controlled Release 56; 1998: 75-83.
27. Gariepy E.R, Leroux J.C. In situ-forming hydrogels- reviews of temperature-sensitive systems. European journal of pharmaceutics and bio pharmaceutics 58; 2004: 409-426.
28. Lin HR, Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. Journal of Controlled Release 69; 2000: 379.
29. Boye T, Gurny R, Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. Journal of Controlled Release 2; 1985:353-361.
30. Le Bourlais CA, Treupel-Acar L, Rhodes Ct, Sado PA, Leverge R. New ophthalmic drug delivery system. Drug Development and Industrial Pharmacy. 21; 1995:19-59.
31. Hui HW, Robinson JR. Ocular drug delivery of progesterone using of bioadhesion polymer. International Journal of Pharmaceutical Sciences 26; 1985:203-213.
32. Davis NM, Farr SJ, Hadgraft J, Kellaway IW. Evaluation of mucoadhesive polymers in ocular drug delivery: part 1, viscous solution. Pharma Research. 8(8); 1991:1039-1043.
33. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. Journal of Controlled Release73; 2001:205-11.
34. Kumar S, Haglund BO, Himmelstein KJ. In situ-forming gels for ophthalmic drug delivery. Journal of ocular pharmacology 10; 1994:47-56.
35. Mohan EC, Jagan Mohan K, Venkatesham A. Preparation and evaluation of in situ gels for ocular drug delivery. Journal of pharmaceutical research 2(6);2009: 1089- 94.
36. Thilak kumar M, Bharathi D, Balasubramaniam J, Kant S, Pandit J.K. pH induced in situ gelling of Indometacin for Sustained ocular delivery. Indian Journal of Pharmaceutical Sciences 67(3); 2005:327-33.
37. Doijad RC, Manvi FV, Malleswara VSN, Prajakta Alase. Sustained ophthalmic delivery of Gatifloxacin from in Situ Gelling System. Indian Journal of Pharmaceutical Sciences 68(6); 2006: 809-814.
38. Bhardwaj TR, Kanwar M, Lal R, Gupta A. Natural gums and modified natural gums as sustained release carriers. Drug Development and Industrial Pharmacy 26; 2000:1025-38.
39. Jansson P.E, Lindberg B. Structural studies of gellan gum, an extracellular polysaccharide elaborated by Pseuomonas elodea. Carbohydrate Research 124;1983: 135-139.
40. Kuo M.S, Mort A.J, Dell A. Identification and location of L-glycerate, an unusual acyl substituent in gellan gum. Carbohydrate Research 156; 1986: 173-187.
41. Morris V.J, Stephen A.M. Bacterial polysaccharides, in food polysaccharides and their application, Marcel Dekker, New York, 1995; 341-375.
42. ®: a novel ion activated in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. International journal of pharmaceutics 57; 1989: 163-168.
43. Kang K.S, Veeder G.T, P.J Mirrasoul P.J, Kaneko T Cottrell I.W Agarlike. Polysaccharide produced by a Pseudomonas species: production and basic properties. Applied and Environmental Microbiology 43; 1982: 1086-1091.
44. Maurice D.M, Srinivas S.P. use of fluorometry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle: comparison with scintigraphy. Journal of Pharmaceutical Sciences 81; 1992: 615-618.
45. Meseguer G, Gurny R, Buri P, Rozier A, Plazonnet B. Gamma scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine. International journal of pharmaceutics 95; 1993:229-234.
46. Haug A, Larsen B, Smidsrod O.A study of the constitution of alginic acid by partial hydrolysis. Acta Chemica Scandinavica 20; 1966: 183-190.
47. Painter T.J, Smidsrod O, Haug A. A computer study of the changes in composition distribution occurring during random depolymerisation of a binary linear heteropolysaccharide. Acta Chemica Scandinavica 22; 1968: 1637-1648.
48. Larsen B., Smidsrod O,. Painter T.J, Haug A. Calculation of the nearest neighbor frequencies in fragments of alginate from the yields of free monomers after partial hydrolysis. Acta Chemica Scandinavica 24; 1970: 726-728.